Nuvo Research(R) reacquires Pennsaid(R) 2% rights to South America, Central America, South Africa and Israel

MISSISSAUGA, ON, Nov. 13, 2014 -- (Healthcare Sales & Marketing Network) - Nuvo Research Inc. (NRI.TO), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced that it has reacquired Pennsaid 2% mark... Biopharmaceuticals, DistributionNuvo Research, Pennsaid 2%, diclofenac
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news